Algo version: 0.98b
Tongfang Kontafarma is listed at the HKSE Exchange
Tongfang Kontafarma [1312.HK]
HKSE Sector: Construction Industry:Drug Manufacturers—Specialty & Generic

Is Tongfang Kontafarma stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Tongfang Kontafarma pays dividends. Last time was Thursday 13th of June 2013 where the investors holding the stock on Monday 27th of May 2013 were paid HKD0.02 per share. Over the last 2 times between 2012 and 2013, Tongfang Kontafarma has paid HKD0.04 with an average of HKD0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Tongfang Kontafarma 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD0.245, you would have made a loss of HKD-0.214 per share or -87.35%

No, the average daily trading liquidity for Tongfang Kontafarma is HKD148 258 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Tongfang Kontafarma has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.35, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Tongfang Kontafarma to be low [0.45 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.